Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Credit Acceptance | CACC | Aug 30, 2024 | 466.53 | -1.23 |
Credit Enhanced Corts Trust Aon Capital A | KTN | Aug 30, 2024 | 26.48 | +0.17 |
Credit Suisse Ag | GLDI | Aug 30, 2024 | 153.34 | -0.06 |
Credit Suisse Ag | SLVO | Aug 30, 2024 | 77.70 | -0.41 |
Credit Suisse Asset Management Income Fund | CIK | Aug 30, 2024 | 3.11 | +0.16 |
Credit Suisse Gold Shares Covered Calls ETN | USOI | Aug 30, 2024 | 70.40 | -1.87 |
Credit Suisse High Yield Bond Fund | DHY | Aug 30, 2024 | 2.14 | +0.94 |
Credo Technology | CRDO | Aug 30, 2024 | 34.91 | -0.82 |
Crescent Capital BDC | CCAP | Aug 30, 2024 | 18.38 | -0.65 |
Crescent Energy | CRGY | Aug 30, 2024 | 11.93 | -1.16 |
Cresud A ADR | CRESY | Aug 30, 2024 | 8.01 | +1.39 |
Crexendo | CXDO | Aug 30, 2024 | 5.16 | -0.77 |
CRH | CRH | Aug 30, 2024 | 90.77 | +2.79 |
Cricut A | CRCT | Aug 30, 2024 | 5.78 | +1.94 |
Crinetics Pharmaceuticals | CRNX | Aug 30, 2024 | 53.06 | +0.68 |
CRISPR Therapeutics | CRSP | Aug 30, 2024 | 47.72 | +0.36 |
Criteo ADR | CRTO | Aug 30, 2024 | 47.43 | +2.84 |
Critical Metals | CRML | Aug 30, 2024 | 8.38 | -3.12 |
Crocs | CROX | Aug 30, 2024 | 146.17 | +0.61 |
Cronos Group | CRON | Aug 30, 2024 | 2.26 | +2.73 |
Cross Country Healthcare | CCRN | Aug 30, 2024 | 14.92 | -1.26 |
Cross Timbers Royalty Royalty Trust | CRT | Aug 30, 2024 | 9.59 | -3.03 |
CrossAmerica Partners LP Unit | CAPL | Aug 30, 2024 | 19.66 | -1.45 |
CrossFirst Bankshares | CFB | Aug 30, 2024 | 17.40 | +0.35 |
CrowdStrike A | CRWD | Aug 30, 2024 | 277.28 | +2.07 |
Crown Castle | CCI | Aug 30, 2024 | 112.02 | +0.30 |
Crown Crafts | CRWS | Aug 30, 2024 | 4.77 | +0.21 |
Crown ElectroKinetics | CRKN | Aug 30, 2024 | 1.41 | -6.93 |
Crown Holdings | CCK | Aug 30, 2024 | 90.41 | +1.41 |
Crown LNG | CGBS | Aug 30, 2024 | 0.38 | 0.00 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.